Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Direxion Daily S&P 500 Bear 3X Shares ETF
SPXS
5
T-Rex 2x Inverse Tesla Daily Target ETF
TSLZ
US Stock MarketDetailed Quotes
VIR Vir Biotechnology
- 6.100
- -0.020-0.33%
Close Apr 28 16:00 ET
- 6.100
- 0.0000.00%
Post 20:01 ET
842.19MMarket Cap-1.59P/E (TTM)
6.300High5.965Low1.00MVolume6.120Open6.120Pre Close6.11MTurnover1.07%Turnover RatioLossP/E (Static)138.06MShares14.45052wk High0.73P/B572.19MFloat Cap4.95052wk Low--Dividend TTM93.80MShs Float141.010Historical High--Div YieldTTM5.47%Amplitude4.950Historical Low6.097Avg Price1Lot Size
About Vir Biotechnology Company
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.
Company Profile
SymbolVIR
Company NameVir Biotechnology
Listing DateOct 11, 2019
Issue Price20.00
Founded2016
CEODr. Marianne De Backer, M.B.A.,M.Sc.,PhD
MarketNASDAQ
Employees408
Fiscal Year Ends12-31
Address1800 Owens Street,Suite 900
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94158
Phone1-415-906-4324
Websitehttp://www.vir.bio
Company Executives
- Name
- Position
- Salary
- Dr. Marianne De Backer, M.B.A.,M.Sc.,PhD
- Chief Executive Officer and Director
- 9.26M
- Brent Sabatini
- Senior Vice President and Chief Accounting Officer
- --
- Jason O'Byrne
- Executive Vice President and Chief Financial Officer
- 1.92M
- Dr. Mark Eisner, M.D.,M.P.H.
- Executive Vice President and Chief Medical Officer
- --
- Vanina de Verneuil
- Executive Vice President, General Counsel and Corporate Secretary
- --
- Dr. Vicki L. Sato, PhD
- Chairman of the Board
- 295.58K
- Dr. George A. Scangos,PhD
- Director
- 269.33K
- Professor Dr. Norbert W. Bischofberger, PhD
- Independent Director
- 445.14K
- Saira Ramasastry, M.Phil,M.S.
- Independent Director
- 285.93K
- Janet Napolitano, J.D.
- Independent Director
- 270.58K
- Robert Taylor Nelsen
- Independent Director
- 263.08K
- Robert J. More
- Independent Director
- 283.08K
- Jeffrey S. Hatfield
- Independent Director
- 279.47K
- Dr. Ramy Farid, PhD
- Independent Director
- 446.34K
- Dr. Elliott Sigal, M.D.,PhD
- Independent Director
- 280.58K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
